BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23805679)

  • 1. [Experience of application of pneumococcus vaccines for studies of humoral immunity].
    Iastrebova NE; Grishchenko NV; Kostinov MP; Salkina OA; Snegova NV; Vaneeva NP
    Zh Mikrobiol Epidemiol Immunobiol; 2013; (2):96-101. PubMed ID: 23805679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [SPECIFIC IMMUNE RESPONSE TO CERTAIN CAPSULE POLYSACCHARIDES OF STREPTOCOCCUS PNEUMONIAE IN HEALTHY BLOOD DONORS AND INDIVIDUALS IMMUNIZED WITH PNEUMOCOCCAL VACCINES].
    Vaneeva NP; Yastrebova NE
    Zh Mikrobiol Epidemiol Immunobiol; 2015; (5):20-6. PubMed ID: 26829849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reactogenicity, safety, immunogenicity and prophylactic effectiveness of polysaccharide pneumococcus vaccine during immunization of HIV-infected patients].
    Fel'dblium IV; Nikolenko VV; Vorob'eva NN; Ivanova ÉS; Shmagel' NG; Khafizov KM; Iurganova GA; Zverev SIa
    Zh Mikrobiol Epidemiol Immunobiol; 2013; (3):52-60. PubMed ID: 24000594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotype-specific anti-pneumococcal IgG and immune competence: critical differences in interpretation criteria when different methods are used.
    Balloch A; Licciardi PV; Tang ML
    J Clin Immunol; 2013 Feb; 33(2):335-41. PubMed ID: 23054341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of previous vaccination with pneumococcal conjugate vaccine on pneumococcal polysaccharide vaccine antibody responses.
    Schaballie H; Wuyts G; Dillaerts D; Frans G; Moens L; Proesmans M; Vermeulen F; De Boeck K; Meyts I; Bossuyt X
    Clin Exp Immunol; 2016 Aug; 185(2):180-9. PubMed ID: 26939935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies.
    Siber GR; Chang I; Baker S; Fernsten P; O'Brien KL; Santosham M; Klugman KP; Madhi SA; Paradiso P; Kohberger R
    Vaccine; 2007 May; 25(19):3816-26. PubMed ID: 17368878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [SYNTHETIC CONJUGATED ANALOGUES OF CAPSULE POLYSACCHARIDES OF PNEUMOCOCCUS - AN INSTRUMENT FOR DETECTION OF POST-VACCINATION ANTIBODIES].
    Kurbatova EA; Akhmatova EA; Akhmatova NK; Egorova NB; Yastrebova NE; Sukhova EV; Tsvetkov YE; Yashunsky DV; Nifantiev NE
    Zh Mikrobiol Epidemiol Immunobiol; 2016 Nov; (6):54-60. PubMed ID: 30695390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of vaccination against pneumococcal infection in children with type 1 diabetes mellitus].
    Tarasova AA; Kostinov MP; Iastrebova NE; Skochilova TV
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (6):45-9. PubMed ID: 18277539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of humoral response to heptavalent pneumococcal conjugate vaccine in HIV-infected children.
    Costa Ide C; Guilardi F; Kmiliauskis MA; Arslanian C; Baldacci ER
    Rev Saude Publica; 2008 Oct; 42(5):844-50. PubMed ID: 18797574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of pneumococcal vaccine in heart transplant recipients.
    Blumberg EA; Brozena SC; Stutman P; Wood D; Phan HM; Musher DM
    Clin Infect Dis; 2001 Jan; 32(2):307-10. PubMed ID: 11170924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Specific antibodies in children with recurrent respiratory infections immunized with pneumo 23 and Act-HIB vaccines].
    Foshina EP; Kostinov MP; Iastrebova NE
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (4):37-40. PubMed ID: 20795384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An immunoenzymatic test for IgG antibody levels against 10 serotypes of Streptococcus pneumoniae].
    Leal-Esteban LC; Rojas JL; Jaimes AL; Montoya JD; Montoya NE; Leiva L; Trujillo-Vargas CM
    Biomedica; 2012; 32(1):92-102. PubMed ID: 23235791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine among Mexican children.
    Espinosa-Padilla SE; Murata C; Estrada-Parra S; Santos-Argumedo L; Mascareñas C; Franco-Paredes C; Espinosa-Rosales FJ
    Arch Med Res; 2012 Jul; 43(5):402-5. PubMed ID: 22868187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The safety and immunogenicity of an heptavalent pneumococcal polysaccharide conjugate vaccine (Prevenar) administered in association with a whole-cell pertussis-based pediatric combination vaccine (DTP-IPV/PRP-T) to French infants with a two-, three-, and four-month schedule].
    Reinert P; Guy M; Girier B; Szelechowski B; Baudoin B; Deberdt P; Wollner A; Kemeny G; Amzallag M; Moat C; Szelechowski C; Villain-Lemoine H; Bouhanna CA; Laudat F
    Arch Pediatr; 2003 Dec; 10(12):1048-55. PubMed ID: 14643532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infants aged 12 months can mount adequate serotype-specific IgG responses to pneumococcal polysaccharide vaccine.
    Balloch A; Licciardi PV; Russell FM; Mulholland EK; Tang ML
    J Allergy Clin Immunol; 2010 Aug; 126(2):395-7. PubMed ID: 20584544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Using Different Response Criteria for Pneumococcal Polysaccharide Vaccination for Assessment of Humoral Immune Status.
    Hoffman TW; van Kessel DA; Rijkers GT
    J Clin Immunol; 2018 Feb; 38(2):149-152. PubMed ID: 29247371
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine.
    Nurkka A; Ahman H; Korkeila M; Jäntti V; Käyhty H; Eskola J
    Pediatr Infect Dis J; 2001 Jan; 20(1):25-33. PubMed ID: 11176563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of vaccination against pneumococcal infection and influenza in children with asthma].
    Andreeva NP; Petrova TI; Golubtsova OI; Kozhevnikova SL; Kostinov MP; Karpocheva SV; Magarshak OO
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (3):74-7. PubMed ID: 17672137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae.
    Briles DE; Hollingshead SK; Nabors GS; Paton JC; Brooks-Walter A
    Vaccine; 2000 Dec; 19 Suppl 1():S87-95. PubMed ID: 11163470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.